These 3 patients initially led us to suspected oxysterol 7¦Á-hydroxylase deficiency. However, sequence analysis of genomic DNA resulted in diagnosis of 2 patients with oxysterol 7¦Á-hydroxylase deficiency and 1 patient with 3¦Â-hydroxy-¦¤5-C27-steroid dehydrogenase/isomerase deficiency. We examined identification of 3¦Â-hydroxy-5-cholestenoic acid and 27-hydroxycholesterol by gas chromatography-mass spectrometry after diagnosis.
Interestingly, we detected a peak for 3¦Â-hydroxy-5-cholestenoic acid in serum and 27-hydroxycholesterol of the neutral sterol in urine from 2 patients who were diagnosed with primary oxysterol 7¦Á-hydroxylase deficiency.
In evaluating infants with cholestasis and excessive 3¦Â-monohydroxy-¦¤5-C24 bile acids in infancy, one needs to conduct C24 bile acid analysis serially. Results can guide performance and interpretation of genomic DNA analysis. Moreover, identification of 3¦Â-hydroxy-5-cholestenoic acid in serum and 27-hydroxycholesterol in urine is highly important for diagnosis of oxysterol 7¦Á-hydroxylase deficiency as is genomic DNA analysis.